Works by Arbizu, Javier

Results: 55
    1
    2

    Clinical Research on Positron Emission Tomography Imaging of the Neuro-Stimulation System in Patients with Cochleo-Vestibular Implants: Is There a Response Beyond the Peripheral Organ?

    Published in:
    Journal of Clinical Medicine, 2025, v. 14, n. 5, p. 1445, doi. 10.3390/jcm14051445
    By:
    • Lorente-Piera, Joan;
    • Prieto, Elena;
    • Ramos de Miguel, Ángel;
    • Manrique, Manuel;
    • Pérez-Fernández, Nicolás;
    • Ramos Macías, Ángel;
    • Monedero Afonso, Jaime;
    • Sanfiel Delgado, Alina;
    • Miranda Ramos, Jorge;
    • Alonso Alonso, Paula;
    • Arbizu, Javier;
    • Manrique-Huarte, Raquel
    Publication type:
    Article
    3

    Updated appropriate use criteria for amyloid and tau PET: A report from the Alzheimer's Association and Society for Nuclear Medicine and Molecular Imaging Workgroup.

    Published in:
    Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2025, v. 21, n. 1, p. 1, doi. 10.1002/alz.14338
    By:
    • Rabinovici, Gil D.;
    • Knopman, David S.;
    • Arbizu, Javier;
    • Benzinger, Tammie L. S.;
    • Donohoe, Kevin J.;
    • Hansson, Oskar;
    • Herscovitch, Peter;
    • Kuo, Phillip H.;
    • Lingler, Jennifer H.;
    • Minoshima, Satoshi;
    • Murray, Melissa E.;
    • Price, Julie C.;
    • Salloway, Stephen P.;
    • Weber, Christopher J.;
    • Carrillo, Maria C.;
    • Johnson, Keith A.
    Publication type:
    Article
    4
    5
    6
    7
    8
    9
    10
    11

    EANM practice guidelines for an appropriate use of PET and SPECT for patients with epilepsy.

    Published in:
    European Journal of Nuclear Medicine & Molecular Imaging, 2024, v. 51, n. 7, p. 1891, doi. 10.1007/s00259-024-06656-3
    By:
    • Traub-Weidinger, Tatjana;
    • Arbizu, Javier;
    • Barthel, Henryk;
    • Boellaard, Ronald;
    • Borgwardt, Lise;
    • Brendel, Matthias;
    • Cecchin, Diego;
    • Chassoux, Francine;
    • Fraioli, Francesco;
    • Garibotto, Valentina;
    • Guedj, Eric;
    • Hammers, Alexander;
    • Law, Ian;
    • Morbelli, Silvia;
    • Tolboom, Nelleke;
    • Van Weehaeghe, Donatienne;
    • Verger, Antoine;
    • Van Paesschen, Wim;
    • von Oertzen, Tim J.;
    • Zucchetta, Pietro
    Publication type:
    Article
    12

    Efficacy of [<sup>177</sup>Lu]Lu-DOTATATE in metastatic neuroendocrine neoplasms of different locations: data from the SEPTRALU study.

    Published in:
    European Journal of Nuclear Medicine & Molecular Imaging, 2023, v. 50, n. 8, p. 2486, doi. 10.1007/s00259-023-06166-8
    By:
    • Mitjavila, Mercedes;
    • Jimenez-Fonseca, Paula;
    • Belló, Pilar;
    • Pubul, Virginia;
    • Percovich, Juan Carlos;
    • Garcia-Burillo, Amparo;
    • Hernando, Jorge;
    • Arbizu, Javier;
    • Rodeño, Emilia;
    • Estorch, Montserrat;
    • Llana, Belén;
    • Castellón, Maribel;
    • García-Cañamaque, Lina;
    • Gajate, Pablo;
    • Riesco, Maria Carmen;
    • Miguel, Maria Begoña;
    • Balaguer-Muñoz, David;
    • Custodio, Ana;
    • Cano, Juana María;
    • Repetto, Alexandra
    Publication type:
    Article
    13
    14
    15

    EANM practice guideline/SNMMI procedure standard for dopaminergic imaging in Parkinsonian syndromes 1.0.

    Published in:
    European Journal of Nuclear Medicine & Molecular Imaging, 2020, v. 47, n. 8, p. 1885, doi. 10.1007/s00259-020-04817-8
    By:
    • Morbelli, Silvia;
    • Esposito, Giuseppe;
    • Arbizu, Javier;
    • Barthel, Henryk;
    • Boellaard, Ronald;
    • Bohnen, Nico I.;
    • Brooks, David J;
    • Darcourt, Jacques;
    • Dickson, John C.;
    • Douglas, David;
    • Drzezga, Alexander;
    • Dubroff, Jacob;
    • Ekmekcioglu, Ozgul;
    • Garibotto, Valentina;
    • Herscovitch, Peter;
    • Kuo, Phillip;
    • Lammertsma, Adriaan;
    • Pappata, Sabina;
    • Peñuelas, Iván;
    • Seibyl, John
    Publication type:
    Article
    16
    17

    Joint EANM/EANO/RANO practice guidelines/SNMMI procedure standards for imaging of gliomas using PET with radiolabelled amino acids and [<sup>18</sup>F]FDG: version 1.0.

    Published in:
    European Journal of Nuclear Medicine & Molecular Imaging, 2019, v. 46, n. 3, p. 540, doi. 10.1007/s00259-018-4207-9
    By:
    • Law, Ian;
    • Albert, Nathalie L.;
    • Arbizu, Javier;
    • Boellaard, Ronald;
    • Drzezga, Alexander;
    • Galldiks, Norbert;
    • la Fougère, Christian;
    • Langen, Karl-Josef;
    • Lopci, Egesta;
    • Lowe, Val;
    • McConathy, Jonathan;
    • Quick, Harald H.;
    • Sattler, Bernhard;
    • Schuster, David M.;
    • Tonn, Jörg-Christian;
    • Weller, Michael
    Publication type:
    Article
    18

    Diagnostic utility of 18F-Fluorodeoxyglucose positron emission tomography (FDG-PET) in asymptomatic subjects at increased risk for Alzheimer’s disease.

    Published in:
    European Journal of Nuclear Medicine & Molecular Imaging, 2018, v. 45, n. 9, p. 1487, doi. 10.1007/s00259-018-4032-1
    By:
    • Drzezga, Alexander;
    • Altomare, Daniele;
    • Festari, Cristina;
    • Arbizu, Javier;
    • Orini, Stefania;
    • Herholz, Karl;
    • Nestor, Peter;
    • Agosta, Federica;
    • Bouwman, Femke;
    • Nobili, Flavio;
    • Walker, Zuzana;
    • Frisoni, Giovanni Battista;
    • Boccardi, Marina
    Publication type:
    Article
    19

    Clinical utility of FDG-PET for the clinical diagnosis in MCI.

    Published in:
    European Journal of Nuclear Medicine & Molecular Imaging, 2018, v. 45, n. 9, p. 1497, doi. 10.1007/s00259-018-4039-7
    By:
    • Arbizu, Javier;
    • Festari, Cristina;
    • Altomare, Daniele;
    • Walker, Zuzana;
    • Bouwman, Femke;
    • Rivolta, Jasmine;
    • Orini, Stefania;
    • Barthel, Henryk;
    • Agosta, Federica;
    • Drzezga, Alexander;
    • Nestor, Peter;
    • Boccardi, Marina;
    • Frisoni, Giovanni Battista;
    • Nobili, Flavio;
    • for the EANM-EAN Task Force for the Prescription of FDG-PET for Dementing Neurodegenerative Disorders
    Publication type:
    Article
    20

    Clinical utility of FDG-PET for the differential diagnosis among the main forms of dementia.

    Published in:
    European Journal of Nuclear Medicine & Molecular Imaging, 2018, v. 45, n. 9, p. 1509, doi. 10.1007/s00259-018-4035-y
    By:
    • Nestor, Peter J.;
    • Altomare, Daniele;
    • Festari, Cristina;
    • Drzezga, Alexander;
    • Rivolta, Jasmine;
    • Walker, Zuzana;
    • Bouwman, Femke;
    • Orini, Stefania;
    • Law, Ian;
    • Agosta, Federica;
    • Arbizu, Javier;
    • Boccardi, Marina;
    • Nobili, Flavio;
    • Frisoni, Giovanni Battista;
    • for the EANM-EAN Task Force for the Prescription of FDG-PET for Dementing Neurodegenerative Disorders
    Publication type:
    Article
    21

    Diagnostic utility of FDG-PET in the differential diagnosis between different forms of primary progressive aphasia.

    Published in:
    European Journal of Nuclear Medicine & Molecular Imaging, 2018, v. 45, n. 9, p. 1526, doi. 10.1007/s00259-018-4034-z
    By:
    • Bouwman, Femke;
    • Orini, Stefania;
    • Gandolfo, Federica;
    • Altomare, Daniele;
    • Festari, Cristina;
    • Agosta, Federica;
    • Arbizu, Javier;
    • Drzezga, Alexander;
    • Nestor, Peter;
    • Nobili, Flavio;
    • Walker, Zuzana;
    • Morbelli, Silvia;
    • Boccardi, Marina;
    • for the EANM-EAN Task Force for the Prescription of FDG-PET for Dementing Neurodegenerative Disorders
    Publication type:
    Article
    22

    Clinical utility of FDG-PET in amyotrophic lateral sclerosis and Huntington’s disease.

    Published in:
    European Journal of Nuclear Medicine & Molecular Imaging, 2018, v. 45, n. 9, p. 1546, doi. 10.1007/s00259-018-4033-0
    By:
    • Agosta, Federica;
    • Altomare, Daniele;
    • Festari, Cristina;
    • Orini, Stefania;
    • Gandolfo, Federica;
    • Boccardi, Marina;
    • Arbizu, Javier;
    • Bouwman, Femke;
    • Drzezga, Alexander;
    • Nestor, Peter;
    • Nobili, Flavio;
    • Walker, Zuzana;
    • Pagani, Marco;
    • for the EANM-EAN Task Force for the Prescription of FDG-PET for Dementing Neurodegenerative Disorders
    Publication type:
    Article
    23

    Clinical utility of FDG PET in Parkinson’s disease and atypical parkinsonism associated with dementia.

    Published in:
    European Journal of Nuclear Medicine & Molecular Imaging, 2018, v. 45, n. 9, p. 1534, doi. 10.1007/s00259-018-4031-2
    By:
    • Walker, Zuzana;
    • Gandolfo, Federica;
    • Orini, Stefania;
    • Garibotto, Valentina;
    • Agosta, Federica;
    • Arbizu, Javier;
    • Bouwman, Femke;
    • Drzezga, Alexander;
    • Nestor, Peter;
    • Boccardi, Marina;
    • Altomare, Daniele;
    • Festari, Cristina;
    • Nobili, Flavio;
    • for the EANM-EAN Task Force for the recommendation of FDG PET for Dementing Neurodegenerative Disorders
    Publication type:
    Article
    24

    Automated assessment of FDG-PET for differential diagnosis in patients with neurodegenerative disorders.

    Published in:
    European Journal of Nuclear Medicine & Molecular Imaging, 2018, v. 45, n. 9, p. 1557, doi. 10.1007/s00259-018-4030-3
    By:
    • Nobili, Flavio;
    • Festari, Cristina;
    • Altomare, Daniele;
    • Agosta, Federica;
    • Orini, Stefania;
    • Van Laere, Koen;
    • Arbizu, Javier;
    • Bouwman, Femke;
    • Drzezga, Alexander;
    • Nestor, Peter;
    • Walker, Zuzana;
    • Boccardi, Marina;
    • For the EANM-EAN Task Force for the Prescription of FDG-PET for Dementing Neurodegenerative Disorders
    Publication type:
    Article
    25
    26
    27

    Metabolic patterns in prion diseases: an FDG PET voxel-based analysis.

    Published in:
    European Journal of Nuclear Medicine & Molecular Imaging, 2015, v. 42, n. 10, p. 1522, doi. 10.1007/s00259-015-3090-x
    By:
    • Prieto, Elena;
    • Domínguez-Prado, Inés;
    • Riverol, Mario;
    • Ortega-Cubero, Sara;
    • Ribelles, María;
    • Luquin, María;
    • Castro, Purificación;
    • Arbizu, Javier
    Publication type:
    Article
    28
    29
    30
    31
    32
    33

    Updated Appropriate Use Criteria for Amyloid and Tau PET: A Report from the Alzheimer's Association and Society for Nuclear Medicine and Molecular Imaging Workgroup.

    Published in:
    Journal of Nuclear Medicine, 2025, v. 66, p. S5, doi. 10.2967/jnumed.124.268756
    By:
    • Rabinovici, Gil D.;
    • Knopman, David S.;
    • Arbizu, Javier;
    • Benzinger, Tammie L.S.;
    • Donohoe, Kevin J.;
    • Hansson, Oskar;
    • Herscovitch, Peter;
    • Kuo, Phillip H.;
    • Lingler, Jennifer H.;
    • Minoshima, Satoshi;
    • Murray, Melissa E.;
    • Price, Julie C.;
    • Salloway, Stephen P.;
    • Weber, Christopher J.;
    • Carrillo, Maria C.;
    • Johnson, Keith A.
    Publication type:
    Article
    34
    35
    36

    Functional Neuroimaging Studies in Asymmetric Hearing Loss.

    Published in:
    Audiology & Neurotology, 2015, v. 20, p. 48, doi. 10.1159/000380748
    By:
    • Cardier, Marisela;
    • Zulueta-Santos, Cristina;
    • Manrique-Huarte, Raquel;
    • Prieto, Elena;
    • García-García, Berta;
    • Arbizu, Javier;
    • Manrique, Manuel
    Publication type:
    Article
    37
    38
    39
    40

    Correction: Hypofractionated radiation therapy and temozolomide in patients with glioblastoma and poor prognostic factors. A prospective, single-institution experience.

    Published in:
    PLoS ONE, 2019, v. 14, n. 7, p. 1, doi. 10.1371/journal.pone.0219614
    By:
    • Jablonska, Paola Anna;
    • Diez-Valle, Ricardo;
    • Gállego Pérez-Larraya, Jaime;
    • Moreno-Jiménez, Marta;
    • Idoate, Miguel Ángel;
    • Arbea, Leire;
    • Tejada, Sonia;
    • Eulate, Maria Reyes Garcia de;
    • Ramos, Luis;
    • Arbizu, Javier;
    • Domínguez, Pablo;
    • Aristu, José Javier
    Publication type:
    Article
    41

    Hypofractionated radiation therapy and temozolomide in patients with glioblastoma and poor prognostic factors. A prospective, single-institution experience.

    Published in:
    PLoS ONE, 2019, v. 14, n. 6, p. 1, doi. 10.1371/journal.pone.0217881
    By:
    • Jablonska, Paola Anna;
    • Diez-Valle, Ricardo;
    • Pérez-Larraya, Jaime Gállego;
    • Moreno-Jiménez, Marta;
    • Idoate, Miguel Ángel;
    • Arbea, Leire;
    • Tejada, Sonia;
    • Garcia de Eulate, Maria Reyes;
    • Ramos, Luis;
    • Arbizu, Javier;
    • Domínguez, Pablo;
    • Aristu, José Javier
    Publication type:
    Article
    42

    Safety and efficacy assessment of flow redistribution by occlusion of intrahepatic vessels prior to radioembolization in the treatment of liver tumors.

    Published in:
    2010
    By:
    • Bilbao JI;
    • Garrastachu P;
    • Herráiz MJ;
    • Rodríguez M;
    • Iñarrairaegui M;
    • Rodríguez J;
    • Hernández C;
    • de la Cuesta AM;
    • Arbizu J;
    • Sangro B;
    • Bilbao, José I;
    • Garrastachu, Puy;
    • Herráiz, María J;
    • Rodríguez, Macarena;
    • Iñarrairaegui, Mercedes;
    • Rodríguez, Javier;
    • Hernández, Carmen;
    • de la Cuesta, Antonio Martínez;
    • Arbizu, Javier;
    • Sangro, Bruno
    Publication type:
    journal article
    43
    44
    45
    46
    47

    Decreased carbon-11-flumazenil binding in early Alzheimer's disease.

    Published in:
    2012
    By:
    • Pascual B;
    • Prieto E;
    • Arbizu J;
    • Marti-Climent JM;
    • Peñuelas I;
    • Quincoces G;
    • Zarauza R;
    • Pappatà S;
    • Masdeu JC;
    • Pascual, Belen;
    • Prieto, Elena;
    • Arbizu, Javier;
    • Marti-Climent, Josep M;
    • Peñuelas, Ivan;
    • Quincoces, Gemma;
    • Zarauza, Rosina;
    • Pappatà, Sabina;
    • Masdeu, Joseph C
    Publication type:
    journal article
    48
    49
    50